Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 25 September 2027
- Last conf. stmt
- 11 September 2026
Haleon UK Holdings (No.2) Limited
- Incorporated
- 24 April 2019 (7 years)
- Previously known as
- Glaxosmithkline Consumer Healthcare Holdings (No.2) Limited (until 16 June 2023)
- Industry
- Activities of other holding companies n.e.c. (64209)
- Owned by
- Accounts type
- Full
- Region
- South East
- Address
- Building 5First FloorThe HeightsWeybridgeKT13 0NY
Officers 4 active
Officer details are public data from the Companies House register.
Director · Appointed 30 July 2026
British
Born September 1980 (46)
Corporate Secretary · Appointed 18 July 2022
Corporate Director · Appointed 18 July 2022
Also at Haleon UK Holdings Limited
Corporate Director · Appointed 18 July 2022
Officer history (13 former)
30 July 2026
24 March 2026
11 September 2023
1 March 2023
18 July 2022
18 July 2022
18 July 2022
Resigned Supran, Bryan as Director
18 July 2022
18 July 2022
18 July 2022
Resigned Baron, Deborah Jane as Director
18 July 2022
18 July 2022
18 July 2022
18 July 2022
Resigned Young, John Douglas as Director
18 July 2022
31 March 2022
Resigned De Decker, Line Raphael Marie as Director
6 October 2021
Appointed De Decker, Line Raphael Marie as Director
6 August 2021
Resigned Slager, Christopher as Director
1 January 2021
Appointed Baron, Deborah Jane as Director
31 December 2020
31 July 2019
31 July 2019
Appointed Slager, Christopher as Director
31 July 2019
31 July 2019
Appointed Young, John Douglas as Director
31 July 2019
Appointed Supran, Bryan as Director
24 April 2019
24 April 2019
24 April 2019
24 April 2019
24 April 2019
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 15 December 2022
Holds 25–50% of voting rights
Private Company Limited By Shares
Reg. no. 14486062
Corporate entity · Notified 24 April 2019
Owns 75–100% of shares
Holds 50–75% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 08998608
Former controllers (2)
15 December 2022
Ceased Haleon PLC — Holds 25–50% of voting rights
17 July 2022
Ceased Pfizer Inc — Holds 25–50% of voting rights
Group structure 6 shown
Ownership group derived from the Companies House PSC register
Haleon Intermediate Holdings Limited Owns 75–100% of shares
Haleon UK Holdings (No.2) Limited This company Holds 25–50% of voting rights
Consumer Healthcare Holdings Limited Owns 75–100% of shares
Haleon UK Holdings Limited Owns 75–100% of shares
Haleon UK Holdings (No.3) Limited Owns 75–100% of shares
Filings 85
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 23 September 2026 | Confirmation statement with no updates | 11 September 2026 | ||
| 6 August 2026 | Appointment of a director | |||
| 8 April 2026 | Termination of appointment of a director | |||
| 2 January 2026 | Director's details changed | |||
| 19 September 2025 | Confirmation statement with no updates | 11 September 2025 |
Some other companies at this address
Other companies in this industry
London
Accrington
Sutton-In-Ashfield
London
Guildford
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →